Aclaris Therapeutics ACRS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$64.92M+50.8% | -$132.07M-49.3% | -$88.48M-1.8% | -$86.91M+4.4% | ||
| $454K-43.7% | $807K-6.5% | $863K+8.3% | $797K-13.7% | ||
| $12.38M+14.1% | $10.86M-47.2% | $20.54M+36.6% | $15.04M+7.0% | ||
| $8.45M+284% | -$4.58M-211% | -$1.47M-500% | $368K-89.9% | ||
| —— | —— | $11.99M— | —— | ||
| -$3.82M-116% | $23.93M— | —— | —— | ||
| $2.3M— | —— | -$26.9M-672% | $4.7M-80.7% | ||
| -$47.11M— | —— | -$78.33M-15.9% | -$67.57M-29.6% | ||
| $111K— | —— | $1.31M+116% | $605K— | ||
| $48.37M+169% | -$69.77M— | —— | —— | ||
| —— | $32K— | —— | $157K— | ||
| $446K+9.0% | $409K+301% | $102K+200% | $34K-98.9% | ||
| -$5.86M-108% | $74.54M— | —— | $72.88M— | ||
| —— | -$15.31M— | —— | —— | ||
| $2.3M— | —— | -$26.9M-672% | $4.7M-80.7% | ||
| —— | $86.91M+1,211% | $6.63M— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | $74.91M+180% | $26.71M-63.3% | $72.74M— | ||
| —— | —— | —— | —— | ||
| —— | $6.25M— | —— | —— | ||
| —— | $44.85M— | —— | —— | ||
| -$3.82M-116% | $23.93M— | —— | —— | ||
| -$47.22M— | —— | -$79.63M-16.8% | -$68.17M— | ||
| -$47.22M— | —— | -$79.63M-16.8% | -$68.17M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aclaris Therapeutics generate?
- Aclaris Therapeutics (ACRS) generated -$52.2M in operating cash flow over the trailing twelve months.
- What is Aclaris Therapeutics's free cash flow?
- After $81.0K of capital expenditures, Aclaris Therapeutics's free cash flow was -$52.3M over the trailing twelve months, up 5.4% year over year.
- Where does Aclaris Therapeutics's cash flow data come from?
- Every line is extracted from Aclaris Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
